Update
$Immutep (IMMP.US)$ Immutep Doses First Participant in In-Human Trial of Antibody Therapy for Autoimmune Diseases
MT Newswires· 8 mins ago
MT Newswires· 8 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Lnova : Oh wow, I wonder what the results will be. Tysm for sharing this
Trytosaveabit OP Lnova : You’re very welcome! I’m bullish on it overall! GL
Lnova Trytosaveabit OP : ty GL to you too
Trytosaveabit OP Lnova : BTW im hoping some good news come from the investors conference tomorrow! Maybe even something good enough to get some above normal volume here? Hehehe
Trytosaveabit OP Lnova : Thank you🩷
Lnova Trytosaveabit OP : oh will there be an investors conference tomorrow? So funny, I was trading some of the stocks you shared this week, and last time I slept, I had a dream that I was at some kind of investors conference
it was more like a convention where investors could come and learn about different companies. Very casual. Funny dream 
Trytosaveabit OP Lnova : Hehehe! Yes tomorrow 8:30 to 8:55AM est!
Lnova : I am interested and curious to learn more about this company now. That is cool that they are working on therapy for Autoimmune diseases
Lnova Trytosaveabit OP : tysm! I will follow it now that I know it is happening
Trytosaveabit OP Lnova : Yes I like it!
View more comments...